Varenzin™-CA1 for Cats & Dogs - Advanced Oral Therapy for Chronic Kidney Disease-Associated Anaemia

Varenzin™-CA1 (Molidustat oral suspension) is a next-generation oral therapeutic formulated for cats and dogs suffering from anemia secondary to chronic kidney disease (CKD). By targeting the hypoxia-inducible factor (HIF) pathway, Varenzin™-CA1 helps stimulate endogenous erythropoietin (EPO) production, supporting healthy red blood cell formation without the need for injectable ESAs.

This therapy offers veterinarians and pet owners a convenient, non-injectable option to manage CKD-related anaemia, improving vitality, appetite, and overall quality of life in companion animals.